New Bay Area Lyme Foundation Study Reports That Only One-Third of Early Lyme Patients with On-Going Symptoms Followed up with their Healthcare ProvidersThe new research, published in Frontiers in Medicine, points to the need for greater follow-up from medical professionals to address potential treatment failures.
Bay Area Lyme Foundation Announces New Executive Director Josh WeinWein brings valuable life sciences and fundraising experience to advance BAL's mission
Twin Cities Lyme Foundation and Bay Area Lyme Foundation Unite Efforts to Further Advance the Fight Against Tick-Borne DiseasesTwin Cities Lyme Foundation Founder Lisa Najarian and her husband Former CNBC Correspondent Peter Najarian to join the Advisory Board of Bay Area Lyme Foundation
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease TestWinner Chao Wang of Arizona State University will receive $150,000 to evaluate a unique diagnostic that uses gold nanoparticles and has been proven in other infectious diseases
New Discovery Identifies “Don’t Eat Me” Protein that Allows Lyme Bacteria to Evade Body’s Immune ResponseStanford University/MIT/UCSF study funded by Bay Area Lyme Foundation offers new direction for tick-borne disease research, paving the way for potential new discoveries
Science Translational Medicine Study Funded by the Bay Area Lyme Foundation Identifies FDA-approved Piperacillin as More Effective, Targeted Treatment for Lyme DiseaseAn additional Science Translational Medicine study also funded by Bay Area Lyme Foundation uncovers how lingering bacterial cell wall molecules may contribute to chronic Lyme symptoms
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme DiseaseBlocking certain fibroblast growth factor receptors is shown to be effective in reducing inflammation and cell death caused by neurological Lyme infection in laboratory studies
Bay Area Lyme Foundation Selects National Winner of the 2024 Emerging Leader Award for Research of Combination Therapies to Treat Chronic Lyme DiseaseWinner Trever Smith, of Tufts University, will collect novel therapeutic data to develop a first-of-its-kind drug interaction compendium for Lyme Disease
New Study Reveals Potential Treatment for Neurological Lyme DiseaseBlocking certain fibroblast growth factor receptors is shown to be effective in reducing inflammation and cell death caused by neurological Lyme infection in laboratory studies
Bay Area Lyme Foundation Now Accepting Applications for 2024 Emerging Leader Award and GrantAnnual grant seeks to attract innovative researchers with a new approach for diagnosing and treating tick-borne diseases
Bay Area Lyme Foundation Celebrates Its 10th Anniversary with a Convergence of Scientists, Clinicians, Patients and Celebrity TalentBAL honors the 2023 Younger Family Emerging Leader Award Winner, announces iHeartRadio partnership and acknowledges the perseverance of patients with persistent Lyme disease
National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme FoundationThe University of California San Francisco Lyme Clinical Trials Center will support innovative clinical trials to develop treatments for patients with persistent Lyme disease
Bay Area Lyme Foundation Researcher Validates New Approach to Overcome Challenges of Lyme Disease Diagnosis in the LabUsing samples from the Lyme Disease Biobank, Raman spectroscopy is identified as a potentially more sensitive test for diagnosing Lyme disease
